EP 0804550 A1 19971105 - EX VIVO ACTIVATION OF IMMUNE CELLS
Title (en)
EX VIVO ACTIVATION OF IMMUNE CELLS
Title (de)
DIE EX VIVO AKTIVIERUNG VON IMMUNZELLEN
Title (fr)
ACTIVATION EX VIVO DES CELLULES IMMUNES
Publication
Application
Priority
- US 9500193 W 19950106
- US 18826294 A 19940127
- US 21440094 A 19940316
- US 30098294 A 19940906
Abstract (en)
[origin: WO9520649A1] Disclosed is a process of activating patient-derived mononuclear cells by exposing the cells in vitro to substances to generate immunoreactive cells. The ex vivo activated cells are then reinfused into the patient to enhance the immune system to treat various forms of cancer, infectious diseases, autoimmune diseases or immune deficiency diseases.
IPC 1-7
IPC 8 full level
A61K 35/14 (2006.01); A61K 35/15 (2015.01); C07K 16/00 (2006.01); C12N 5/0783 (2010.01)
CPC (source: EP)
A61K 39/461 (2023.05); A61K 39/4611 (2023.05); A61K 39/4621 (2023.05); A61K 39/46433 (2023.05); A61K 39/4644 (2023.05); A61K 39/464838 (2023.05); C07K 16/00 (2013.01); C12N 5/0636 (2013.01); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05); A61K 2239/56 (2023.05); C12N 2501/01 (2013.01); C12N 2501/515 (2013.01); C12N 2502/11 (2013.01)
Designated contracting state (EPC)
DE ES FR GB IT
DOCDB simple family (publication)
WO 9520649 A1 19950803; AU 1524095 A 19950815; EP 0804550 A1 19971105; EP 0804550 A4 19980805
DOCDB simple family (application)
US 9500193 W 19950106; AU 1524095 A 19950106; EP 95906781 A 19950106